FFP-104

N/A

Report date: 2022/11/25 17:01:32

Base Information

Drug NameFFP-104
Drug Alias NameFFP-104
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 inhibitors
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsCrohn DiseaseLiver Cirrhosis, Biliary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumNetherlandsUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFf Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFast Forward Pharmaceuticals Bv
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseLiver Cirrhosis, Biliary

Other Information

ATC CodeN/A
Related LinksN/A